Freenome’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Freenome is a biotechnology company that develops a multiomics platform for early detection of cancer. Read more

Freenome is a biotechnology company that develops a multiomics platform for early detection of cancer. Read more

Gabriel Otte's photo - Co-Founder & CEO of Freenome

Co-Founder & CEO

Gabriel Otte

CEO Approval Rating

91/100

Founded:

2016

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Guardant Health is one of Freenome's top rivals. Guardant Health is a Public company that was founded in 2013 in Redwood City, California. Like Freenome, Guardant Health also works within the Biotechnology industry. Compared to Freenome, Guardant Health has 542 more employees.

Exosome Diagnostics is seen as one of Freenome's biggest rivals. Exosome Diagnostics was founded in 2008 in Waltham, Massachusetts. Like Freenome, Exosome Diagnostics also competes in the Biotechnology sector. Exosome Diagnostics generates $3.5M more revenue than Freenome.

Biodesix is one of Freenome's top competitors. Biodesix was founded in 2005, and its headquarters is in Boulder, Colorado. Like Freenome, Biodesix also competes in the Biotechnology space. Biodesix has NaN fewer employees than Freenome.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 80 a good estimate for Freenome's Employee count?

Acquisitions

No recent acquisitions found related to Freenome

Freenome Funding History

$5.6M$77.6M$237.6M$507.6M

Since Freenome was founded in 2016, it has participated in 4 rounds of funding. In total Freenome has raised $507.6M. Freenome's last funding round was on Aug 2020 for a total of $270.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series C
Aug 2020
$270M

Bain Capital Life Sciences

Series B
Jun 2019
$160M
Series A
Feb 2017
$72M
Seed
May 2016
$5.6M

Since Freenome was founded in 2016, it has participated in 4 rounds of funding. In total Freenome has raised $507.6M. Freenome's last funding round was on Aug 2020 for a total of $270.0M

Investments

No recent investments found related to Freenome

Freenome News

February 1, 2020CNBC

These start-ups are racing to help doctors detect cancer early with a simple blood test

Freenome, Grail, Thrive and others are hoping to bring to market tests that can detect cancer in the ... See more »
January 23, 2020MarketScreener

Announces Encouraging Performance Data for Its Multiomics Blood Test to Detect Early-Stage Colorectal Cancer in a Prospective, Multi-Center Clinical Study

(marketscreener.com) Data to be presented at the 2020 American Society of Clinical Oncology Gastroint... See more »
September 3, 2019BioPortfolio

Freenome inks biomarker development deal with ADC Therapeutics

Freenomes multiomics platform is being used in a Phase II clinical trial to help identify patients mo... See more »
August 1, 2019Pulse2.0

This Multiomics Blood Testing Platform Raised $160 Million To Help Detect Cancer Earlier

Freenome -- a biotechnology company that pioneered a multiomics platform for early cancer detection -... See more »
July 25, 2019BioPortfolio

Freenome secures £128m funds for multiomics cancer blood testing platform

With the latest series B funding led by RA Capital Management and Polaris Partners Freenomes total fi... See more »
October 9, 2018BioPortfolio

Freenome Unveils Promising Early Data on Colorectal Cancer Screening Test at American College of Gastroenterology Annual Meeting

South San Franciscobased Freenome the leading artificial intelligence AI genomics company is presenti... See more »

Freenome Blogs

Freenome Press Releases

Social Statistics

Headquarters

259 East Grand Avenue 5th Floor

South San Francisco, California94080

1-831-704-6883

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Freenome is a biotechnology company that develops a multiomics platform for early detection of cancer. Freenome was founded in 2016. Freenome's headquarters is located in South San Francisco, California, USA 94080. It has raised 507.6M in 4 rounds. Th...

CEO

Freenome's Co-Founder & CEO, Gabriel Otte, currently has an approval rating of 91%. Freenome's primary competitors are Guardant Health, Exosome Diagnostics & Biodesix.

Website

freenome.com

Frequently Asked Questions about Freenome

  1. When was Freenome founded?

    Freenome was founded in 2016
  2. Who is Freenome's CEO?

    Freenome's CEO is Gabriel Otte
  3. How much revenue does Freenome generate?

    Freenome generates $3.5M in revenue
  4. How much funding does Freenome have?

    Freenome has historically raised $507.6M in funding
  1. Where is Freenome's headquarters?

    Freenome's headquarters is in South San Francisco California, USA
  2. How many employees does Freenome have?

    Freenome has 80 employees
  3. What sector does Freenome operate in?

    Freenome is in Biotechnology
  4. Who are Freenome's competitors?

    Freenome's top competitors are Guardant Health, Exosome Diagnostics, Biodesix